Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma.

Comprehensive Genomic Analysis in NRG Oncology/RTOG 9802: A Phase III Trial of Radiation Versus Radiation Plus Procarbazine, Lomustine (CCNU), and Vincristine in High-Risk Low-Grade Glioma. J Clin Oncol. 2020 10 10; 38(29):3407-3417.

View in: PubMed

subject areas

Adult
Antineoplastic Combined Chemotherapy Protocols
Brain Neoplasms
Clinical Trials, Phase III as Topic
DNA Methylation
DNA Modification Methylases
DNA Repair Enzymes
Female
Glioma
Humans
Immunohistochemistry
Isocitrate Dehydrogenase
Lomustine
Male
Middle Aged
Neoplasm Grading
Procarbazine
Promoter Regions, Genetic
Proportional Hazards Models
Tumor Suppressor Proteins
Vincristine

authors with profiles

Cynthia Timmers